[HTML][HTML] Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance
J Cooper, FG Giancotti - Cancer cell, 2019 - cell.com
Integrins mediate cell adhesion and transmit mechanical and chemical signals to the cell
interior. Various mechanisms deregulate integrin signaling in cancer, empowering tumor …
interior. Various mechanisms deregulate integrin signaling in cancer, empowering tumor …
Tumor cell infiltration into the brain in glioblastoma: from mechanisms to clinical perspectives
Simple Summary The estimated survival time for glioblastoma patients is extremely low; only
about 5% of patients survive five years post diagnosis. The standard of care for glioblastoma …
about 5% of patients survive five years post diagnosis. The standard of care for glioblastoma …
Are integrins still practicable targets for anti-cancer therapy?
B Alday-Parejo, R Stupp, C Rüegg - Cancers, 2019 - mdpi.com
Correlative clinical evidence and experimental observations indicate that integrin adhesion
receptors, in particular those of the αV family, are relevant to cancer cell features, including …
receptors, in particular those of the αV family, are relevant to cancer cell features, including …
Targeting glioblastoma stem cells: a review on biomarkers, signal pathways and targeted therapy
X Tang, C Zuo, P Fang, G Liu, Y Qiu, Y Huang… - Frontiers in …, 2021 - frontiersin.org
Glioblastoma (GBM) remains the most lethal and common primary brain tumor, even after
treatment with multiple therapies, such as surgical resection, chemotherapy, and radiation …
treatment with multiple therapies, such as surgical resection, chemotherapy, and radiation …
Integrins regulate stemness in solid tumor: an emerging therapeutic target
J Xiong, L Yan, C Zou, K Wang, M Chen, B Xu… - Journal of Hematology & …, 2021 - Springer
Integrins are the adhesion molecules and transmembrane receptors that consist of α and β
subunits. After binding to extracellular matrix components, integrins trigger intracellular …
subunits. After binding to extracellular matrix components, integrins trigger intracellular …
The biological functions and clinical applications of integrins in cancers
C Su, J Li, L Zhang, H Wang, F Wang, Y Tao… - Frontiers in …, 2020 - frontiersin.org
Integrins are the adhesion molecules and receptors of extracellular matrix (ECM). They
mediate the interactions between cells-cells and cells-ECM. The crosstalk between cancer …
mediate the interactions between cells-cells and cells-ECM. The crosstalk between cancer …
Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer
Glioblastoma ranks among the most lethal of all human cancers. Glioblastomas display
striking cellular heterogeneity, with stem-like glioblastoma stem cells (GSCs) at the apex …
striking cellular heterogeneity, with stem-like glioblastoma stem cells (GSCs) at the apex …
Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma
The interplay between glioma stem cells (GSCs) and the tumor microenvironment plays
crucial roles in promoting malignant growth of glioblastoma (GBM), the most lethal brain …
crucial roles in promoting malignant growth of glioblastoma (GBM), the most lethal brain …
Integrin signaling in glioma pathogenesis: from biology to therapy
A Ellert-Miklaszewska, K Poleszak… - International journal of …, 2020 - mdpi.com
Integrins are a large family of transmembrane adhesion receptors, which play a key role in
interactions of a cell with the surrounding stroma. Integrins are comprised of non-covalently …
interactions of a cell with the surrounding stroma. Integrins are comprised of non-covalently …
Invasion of white matter tracts by glioma stem cells is regulated by a NOTCH1–SOX2 positive-feedback loop
J Wang, SL Xu, JJ Duan, L Yi, YF Guo, Y Shi, L Li… - Nature …, 2019 - nature.com
Early invasive growth along specific anatomical structures, especially the white matter tract,
is regarded as one of the main causes of poor therapeutic outcome of people with gliomas …
is regarded as one of the main causes of poor therapeutic outcome of people with gliomas …